cutaneous T-cell lymphoma (CTCL)

A Mindfulness-Based Smartphone Application Intervention to Improve the Quality of Life of Patients with CTCL
CTCL
by Nishad Sathe, MD on
Dr. Nishad Sathe, Next Steps Correspondent, interviewed Lily M. Parker, second year medical student at the University of South Florida Morsani College of Medicine, to dig deeper on her research study titled “A mindfulness-based smartphone application intervention to improve the quality of life of patients with cutaneous T-cell lymphoma. A pilot/feasibility study, and an analysis of social determ …

Continue reading "A Mindfulness-Based Smartphone Application Intervention to Improve the Quality of Life of Patients with CTCL"

Atopic Dermatitis (AD) Treatment Initiation and Monitoring
atopic dermatitis (AD)
by Mojgan Hosseinipour, DO, FAAD on
During the recent DERM2O22 NP/PA CME conference held July 28-31, 2022, Drs. David Cohen, Brad Glick, and Adam Friedman led a case-based panel discussion on atopic dermatitis (AD) treatment initiation and monitoring. This article provides a summary of their discussion and recommendations.  CASE 1 51-year-old male with a 20-year history of AD. The patient was first seen in September 2015 with BSA …

Continue reading "Atopic Dermatitis (AD) Treatment Initiation and Monitoring"

Hypopigmented Mycosis Fungoides: A Clinical Mimicker of Vitiligo
Hypopigmented Mycosis Fungoides (HMF)
by NEXT STEPS IN DERM TEAM on
Hypopigmented mycosis fungoides (HMF) is a rare variant of cutaneous T-cell lymphoma (CTCL) that often manifests in younger patients with darker skin types in a centripetal distribution.¹ Average age of diagnosis is often 14 years.² The diagnosis is often missed due to its low incidence and lack of clinical suspicion. Misdiagnosis and failure to obtain biopsies lead to a long latency period fr …

Continue reading "Hypopigmented Mycosis Fungoides: A Clinical Mimicker of Vitiligo"